In this study, we found that valproic acid also attenuated diabetes-induced upregulation of complement genes, such as C5aR1 and C5aR2, in the diabetic kidney, suggesting a new pathway regulated by valproic acid. The gene discussed is C5AR2; the disease is diabetes mellitus.